Shares of Seattle, Washington-based Atossa Therapeutics (ATOS) have been on a tear this year, at one point up nine-fold from their early-January share price. However, the stock has come down quite a bit in the last couple of weeks, falling 36% from its late-June high of more than $8 a share. But that's okay, says Maxim analyst Jason McCarthy: Not only did the decline come in response to no particular bad news. Rather, momentum investors may simply have cashed out their profits after the stock was added to the Russell 2000 and Russell 3000 Indexes on June 28.
https://www.tipranks.com/news/article/atossas-covid-19-treatment-has-potential-says-analyst
Atossa Therapeutics (NASDAQ:ATOS)
Historical Stock Chart
From Apr 2022 to May 2022 Click Here for more Atossa Therapeutics Charts.
Atossa Therapeutics (NASDAQ:ATOS)
Historical Stock Chart
From May 2021 to May 2022 Click Here for more Atossa Therapeutics Charts.